Arbutus Biopharma (ABUS) Stock Forecast for 2028. Abus Prediction

Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …

Arbutus Biopharma Corp. (ABUS) Stock Forecast for 2028. Abus Prediction

Updated: January 15, 2024 (10:29)

Sector: Healthcare

The share price of Arbutus Biopharma Corp. (ABUS) now

What analysts predict: $4.4
52-week High/Low: $3.29 / $1.69

50/200 Day Moving Average: $2.754 / $2.254

This figure corresponds to the Average Price over the previous 50/200 days. For Arbutus Biopharma stocks, the 50-day moving average is the resistance level today.

For Arbutus Biopharma stocks, the 200-day moving average is the resistance level today.

Are you interested in Arbutus Biopharma Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Arbutus Biopharma stock price in 2028. How much will one Arbutus Biopharma share be worth in 2028? Is it worth taking profit / loss on ABUS stock now or waiting? What are analysts' forecasts for Arbutus Biopharma stock?

We forecast Arbutus Biopharma stock performance using neural networks based on historical data on ABUS stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.

Arbutus Biopharma Corp. stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Arbutus Biopharma analysts is $4.4. Today 200 Day Moving Average is the support level (2.254 $). 50 Day Moving Average is the support level (2.754 $).

Historical and forecast chart of Arbutus Biopharma Corp. stock

The chart below shows the historical price of Arbutus Biopharma stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ABUS stock price can be found in the table below.

Arbutus Biopharma (ABUS) Forecast for 2028

Month Target Pes. Opt. Vol., %

Arbutus Biopharma information and performance

Arbutus Biopharma Address


Market Capitalization: 526 111 000 $

Market capitalization of the Arbutus Biopharma Corp. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ABUS shares in the company outstanding by the market price of one share.

EBITDA: -76 630 000 $

EBITDA of Arbutus Biopharma is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.44

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: -0.657
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 22.05

Enterprise Value (EV) /Revenue

EV To EBITDA: -5.64

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 180175000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Arbutus Biopharma price target for 2028 by month

Related stocks from Healthcare sector


All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.